<a id="article1.body1.sec3.p3" name="article1.body1.sec3.p3"></a><p>Moreover, SMAR1 leads to reduced migration and invasion in both poorly and highly metastatic breast carcinoma cell lines irrespective of p53 status in both transient and stably SMAR1 transfected cells through downregulation of TGFβ signaling and its target gene expression including CUTL1. Earlier we have reported that SMAR1 inhibits ERK phosphorylation <a href="#pone.0000660-Jalota1">[37]</a> that may contribute to decreased phospho-Smad2 levels and thus inhibits TGFβ signaling. SMAR1 is also able to reduce metastatic potential of B16F1 cells <em>in-vivo</em> in mice model. Microarray analysis done in SMAR1 stable clone, showing downregulation of various oncogenes, Cyclins, focal-adhesion molecules, TGFβ related genes and upregulation of various growth inhibitory, DNA repair and stress response genes also indicated anti-tumorigenic and anti-metastatic function of SMAR1. Our results establish SMAR1, as a critical regulator of TGFβ signaling cascade that finally affect CUTL1 expression. Downregulation of SMAR1 in high-grade breast carcinoma can be directly correlated with activated TGFβ signaling and its downstream target genes that consequently lead to increased tumor metastasis. Thus, we propose that SMAR1 acts as a key regulator of two major physiological processes of cellular proliferation and metastases in breast cancer by interplaying between p53 and TGFβ pathway and thereby prevent tumor cells to proliferate and metastasize (<a href="#pone-0000660-g009">Figure 9</a>).</p>
<a id="article1.body1.sec3.p4" name="article1.body1.sec3.p4"></a><p>In brief, we report SMAR1 as a transcriptional target of p53. Increased SMAR1 expression in turn results in p53 stabilization. Earlier PTEN-Akt, p14/19 ARF and Rb are reported to positively regulated p53 <a href="#pone.0000660-Harris1">[49]</a>, here we report another protein SMAR1 that can also regulate p53 via positive feed forward loop. SMAR1 is downregulated in advanced breast carcinoma stages due to deregulated p53 function that again correlates with the elevated Cyclin D1 expression. Moreover, SMAR1 overexpression in both poorly and highly metastatic breast carcinoma cell lines leads to reduced migration and invasion irrespective of p53 status suggesting that the effect of SMAR1 in regulating genes involved in tumor migration and invasion is downstream of p53 although the wild type expression of SMAR1 is regulated by p53. Doxorubicin mediated upregulation of SMAR1 is p53 dependent and thus it does not function as efficiently in p53 mutated or null breast cancer cell line. Reduced migration and invasion observed in SMAR1 overexpressing cells were thus correlated to downregulated TGFβ signaling and inhibition of downstream kinase phosphorylation namely Smad2 phosphorylation. Further, various TGFβ target genes were observed to be downregulated such as <em>cutl1</em> that promote tumor cell metastases <a href="#pone.0000660-Michl1">[26]</a>. SMAR1 also inhibited the expression of Fibronectin, Vinculin and JAM2 that are involved in promoting cell-extracellular matrix adhesion, cell spreading and migration <a href="#pone.0000660-Ezzell1">[42]</a>–<a href="#pone.0000660-JohnsonLeger1">[48]</a>, suggesting that SMAR1 might prevent tumor cell metastases through negative regulation of these proteins. Thus, SMAR1 is an important anti-tumorigenic protein that regulates cell growth and metastases in breast cancer and acts as a connecting link between p53 and TGFβ pathway preventing tumor cells to proliferate and metastasize.</p>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Mammalian cell culture and transfection</h4>
<a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1"></a><p>All cell lines were obtained from ATCC except Hct116 p53<sup>−/−</sup> and H1299 p53<sup>−/−</sup> cells that were obtained as kind gift from Dr. Kumar Somasundaram (Indian Institute of Science, Bangalore, India). Breast cancer cell line MCF7, Hbl100, mouse melanoma cell line B16F1, SMAR1 stable clone <a href="#pone.0000660-Kaul1">[38]</a>, Hct116 p53<sup>−/−</sup>, H1299 p53<sup>−/−</sup> and human kidney embryonic cell line 293 were maintained in DMEM supplemented with 10% fetal calf serum (Invitrogen) in the presence of 5% CO<sub>2</sub> at 37°C. MDA-MB-231, MDA-MB-468 cells were maintained in L15 media (Invitrogen) and PC3 cell lines were cultured Ham's F12 media (Invitrogen) supplemented with 10% fetal calf serum (Invitrogen) in presence of 5% CO<sub>2</sub> at 37°C. Cells were seeded at a density of 1×10<sup>6</sup> per 30 mm dish and cultured for 24 hr before transfection. One microgram of pEGFP-vector or 1 µg of pEGFP-SMAR1 plasmid DNA were used for transfection using Lipofectamine 2000, following manufacturers protocol (Invitrogen). For Luciferase promoter assays, SMAR1 promoter construct and pEGFP-p53 were used for transfection.</p>


<h4>Plasmids and siRNA</h4>
<a id="article1.body1.sec4.sec2.p1" name="article1.body1.sec4.sec2.p1"></a><p>pBK-CMV-SMAR1 and GFP-SMAR1 expression constructs were used to overexpress SMAR1. Following siRNA specific for SMAR1 (Ambion, Austin, TX): 5′-UAACCCUGAGAUGCGGGUA with scrambled control RNA 5′-UACCGUAGGCAUGCAAUGG at 100 pM concentrations for 48 hr, with a pretreatment of 8 hr, was used to knock-down SMAR1 <a href="#pone.0000660-Jalota1">[37]</a>.</p>


<h4>SMAR1 promoter cloning and luciferase reporter assay</h4>
<a id="article1.body1.sec4.sec3.p1" name="article1.body1.sec4.sec3.p1"></a><p>SMAR1 promoter sequence was identified and characterized using BLAST, Pro-Scan and Clustal W analysis. 950 bp promoter sequence was amplified from human genomic DNA using the following primer 5′-ATGATGTAGTTCCTGGGGTTTGA-3′ and 5′-CTGCGATAATGGCGTCCGTC-3′ (Genomechanix, USA) and was cloned in Luciferase reporter vector pGL3 basic via subcloning in pGMT-easy and pSP72 vector (Promega). Utilizing an internal <em>PvuII</em> restriction enzyme site orientation of promoter was checked and both sense and antisense constructs were selected for further experiments. SMAR1 promoter construct (0.5–2.0 µg/ml) was transfected with or without Doxorubicin (0.5 uM) treatment in p53 wild type cell lines. One microgram of GFP-p53, p53 Serine-15-Alanine and p53 Serine 20-Alanine plasmid constructs were used to express WT or single amino acid mutant p53 in p53 null cell lines with or without Doxorubicin (0.5 µM) treatment. Cells were harvested after 24 hr post transfection and/or treatment and were subjected to Dual Luciferase assay as per manufacturer's instruction (Promega). Luciferase activity was measured using Fluoroskan Ascent Luminometer (Lab Systems). All the assays were done in triplicates.</p>


<h4>Reverse Transcriptase and Real-Time PCR</h4>
<a id="article1.body1.sec4.sec4.p1" name="article1.body1.sec4.sec4.p1"></a><p>2×10<sup>5</sup> cells treated with Doxorubicin (0.2–1.0 µM; Sigma) or human recombinant TGFβ1 (10 ng/ml; Sigma) for 0–12 hours were harvested and total RNA isolated was subjected to cDNA synthesis following the manufacturer's instruction (Invitrogen). PCR was done using specific primers for SMAR1 F-5′-GCATTGAGGCCAAGCTGAAAGCTC-3′ and R-5′-CGGAGTTCAGGGTGATGAGTGTGAC-3′. β-actin was amplified using following primers F-5′-TACCACTGGCATCGTGATGGACT-3′ and R-5′-TTTCTGCATCCTGTCGGAAAT-3′, as a loading control. Real time RT-PCR was performed by icycler iQ thermal cycler system (Biorad) using double stranded DNA specific flurophore SYBR Green (BioRad) as per our published protocol <a href="#pone.0000660-Rampalli1">[36]</a>. Quantitation was performed with three different sets of cDNA samples. Graphs were plotted and statistical analysis was done using Sigma Plot.</p>


<h4>Immunoblotting and antibodies</h4>
<a id="article1.body1.sec4.sec5.p1" name="article1.body1.sec4.sec5.p1"></a><p>Cells were scraped, washed with 1× PBS in different time intervals and lysed in DIGNAM buffer. Protein concentrations were estimated using Bradford reagent (Biorad). Equal amount of protein was loaded for immunoblotting. Following SDS-PAGE, resolved proteins were electroblotted on PVDF membrane (Amersham). The membrane was blocked overnight in TBS containing 0.1% Tween- 20 (TBST) and 10% BSA. The membrane was then probed with primary antibody in TBST for 2 hrs at RT or overnight at 4°C followed by three 10 min TBST washes at room temperature. Incubation with the secondary antibody was done for 1 hr, three 10 min TBST washes were given prior to chemiluminiscence detection using ECL substrate (Amersham). All antibodies for Western blots were obtained from Santa Cruz. Polyclonal rabbit antiserum was raised against recombinant GST-SMAR1 truncated (400–548 aa) fusion protein <a href="#pone.0000660-Jalota1">[37]</a>. Mouse α-Cyclin D1, rabbit α-p27, TGFβ1, TGFβRI, phospho-Smad2 were procured from Cell Signaling and rabbit α-acetylated p53-K373/382 from Upstate Signaling. Secondary antibodies, goat α-mouse-HRP and goat α-rabbit HRP were purchased from Biorad.</p>


<h4>Immuno-flourescence</h4>
<a id="article1.body1.sec4.sec6.p1" name="article1.body1.sec4.sec6.p1"></a><p>For Immunostaining 1×10<sup>5</sup> cells were plated on coverslips and immunostained for SMAR1 using rabbit polyclonal α-SMAR1 and detected with secondary antibody mix containing FITC-conjugated α-rabbit IgG antibody (Bangalore Genei) following the standard protocol <a href="#pone.0000660-Jalota1">[37]</a>. F-actin staining was done using Alexa Fluor 488 conjugated phalloidin (1U/ml; Molecular Probes, Invitrogen). Breast carcinoma tissues were obtained from KEM Hospital, Pune and Armed Force Medical College (AFMC, Pune). Histological grading of tumor tissues was done following modified Bloom and Richardson guidelines <a href="#pone.0000660-Henderson1">[50]</a>. Immunoflourescence staining was carried out after de-parafinization by heating at 60°C for 5 minutes followed by partial rehydration in 100% and 95% ethanol. Antigen retrieval was done by boiling in 0.01 M citric acid. BSA blocked sections were stained with respective primary antibodies and detected by donkey α-Rabbit-FITC (Bangalore Genei), donkey α-Mouse Cy3 (Chemicon) and donkey α-Goat Cy5 (Chemicon) secondary antibodies. Nucleus was stained with Propidium Iodide (Sigma) or DAPI (Sigma). Sections and coverslides were mounted in anti-fade mountant medium (Sigma) and analyzed by Confocal laser microscope (LSM 510 version 2.01; Ziess, Thornwood, NY).</p>


<h4>Enzyme mobility shift assay</h4>
<a id="article1.body1.sec4.sec7.p1" name="article1.body1.sec4.sec7.p1"></a><p>For EMSA, probes were PCR labeled using α<sup>32</sup>p dCTP in a 25 µl PCR reaction. For amplification of −369 to −569 (Probe I) primers used were (For 5′-TGCTGGGATTAAAGGTGTGC-3′, Rev 5′-CCTGTTTCCTGCCCGTTCCC-3′) and −170 to −480 (Probe II) primers used were (For 5′-GGGAACGGGCAGGAAACAG-3′, Rev 5′-TTCCGGGCTCGTTCAGTGGC-3′). PCR products were then eluted from native polyacrylamide gel by phenol-chloroform method and subsequent precipitation by 70% ethanol. Oligonucleotide labeling was done by klenowing reaction using α<sup>32</sup> p dCTP in a 20 µl reaction containing 25 µM dATG mix, Klenow buffer and 0.5 U of Klenow (Invitrogen). Probe purification was done using Probequant G 50 column (Amersham). Binding reactions were performed in a 10 µl total volume containing 10 mM Tris (pH 7.5), 1 mM DTT, 50 mM KCl, 50 mM NaCl, 5 mM MgCl<sub>2</sub>, 5% glycerol, 1 µg double stranded poly (dI-dC), 10 µg BSA and 10 µg of nuclear lysate. Samples were incubated for 5 min at room temperature prior to addition of radiolabelled probe. Then the samples were incubated for 15 min at room temperature, the products of binding reactions were resolved by 8% native polyacrylamide gel electrophoresis. The gels were dried under vacuum and processed for autoradiography.</p>


<h4>Chromatin immunoprecipitation assays</h4>
<a id="article1.body1.sec4.sec8.p1" name="article1.body1.sec4.sec8.p1"></a><p>Chromatin immunoprecipitation (ChIP) assays were performed using Chromatin Immunoprecipitation assay kit (Upstate Biotechnology) following manufacturer's instructions. 1×10<sup>6</sup> cells were plated per 30 mm dish and treated with 0.5 uM Doxorubicin for 6 hrs. After treatments, DNA-protein interactions were fixed with 1% formaldehyde at 37°C for 10 min. ChIP assays were carried out using α-p53, (Santa Cruz) α-Ac-p53-K372/383 (Upstate Signaling) and α-H3K9 (Cell Signaling) antibodies. Input DNA, Rabbit IgG (r-IgG), and Mouse IgG (m-IgG) pulled DNA served as controls for all the experiments. DNA immunoprecipitated was then subjected to 35 cycles of PCR using primers for probe I. Amplified PCR products were analysed by native PAGE (10% Poly acrylamide gel) and ethidium bromide staining.</p>


<h4>Wound healing, migration and invasion assays</h4>
<a id="article1.body1.sec4.sec9.p1" name="article1.body1.sec4.sec9.p1"></a><p>An artificial wound was made using a 10 µl pipette tip on confluent cell monolayers of vector or GFP-SMAR1 transfected cells, after 8 hr serum starvation and cell migration was observed in serum containing medium. Images were taken using Motorized IX-81 inverted microscope attached with DP70 CCD camera (Olympus). The number of cells migrated towards the wound was calculated per 10<sup>5</sup> µm<sup>2</sup> wound area after 12 hr. Cell migration and invasion were determined by using the modified two-chamber migration/invasion assay (8 µm pore size membrane uncoated/coated with Matrigel, BD Biosciences) according to the manufacture's instructions. 2×10<sup>5</sup> cells were seeded in serum free media on the upper migration/invasion chamber and were incubated in the lower chamber containing media supplemented with 10% serum for 24 hrs in humidified tissue culture incubator, at 37°C, 5% CO<sub>2</sub>. After 24 hrs, cells from the upper chamber were removed by scrubbing and the migrated/invaded cells in the lower chamber were fixed and stained with 100% methanol and 1% Toluidine Blue respectively. Quantification was performed by counting the number of stained cells per 100 µm<sup>2</sup> area migrated/invaded to the lower chamber.</p>


<h4>Time-lapse video microscopy</h4>
<a id="article1.body1.sec4.sec10.p1" name="article1.body1.sec4.sec10.p1"></a><p>Time-lapse imaging of migrating cells in wound healing assay was performed on an Axiovert 200M microscope (Carl Zeiss, Germany) over 10 hr in serum containing medium in humidified chamber at 37°C and 5% CO<sub>2</sub> atmosphere. Images were obtained every 2 min using a 10× phase objective of NA 0.25 and analyzed using image analysis software Metamorph Universal Imaging,USA. A minimum of 45 cells per sample were tracked to get the total distance traveled over a time period of 10 hr time period. The average migration speed in µm/hr was calculated and graphs were plotted using Microsoft Excel and Sigma plot program.</p>


<h4><em>In-vivo</em> metastases assay</h4>
<a id="article1.body1.sec4.sec11.p1" name="article1.body1.sec4.sec11.p1"></a><p>Male MNRI nu/nu mice (6 mice/group) were injected with 10<sup>6</sup> B16F1 control or B16F1 stably expressing SMAR1 cells/0.1 ml PBS into the tail vain. Mice were sacrificed after 24 days post injection and serial sections of the liver and spleen cut at the distance of 150 µm from each other were hematoxylin-eosin (HE) stained. The number of hepatic and splenic colonies was counted in 15 sections per liver and spleen.</p>


<h4>Microarray analysis</h4>
<a id="article1.body1.sec4.sec12.p1" name="article1.body1.sec4.sec12.p1"></a><p>Microarray experiment was commercially done by Agilant Genotypic Technology, Bangalore, India. Significantly regulated genes are presented with the fold &gt;0.5 for downregulation and &gt;1 for upregulation between the mean expression values of B16F1 control and SMAR1 stable clones in triplicate experiments.</p>

</div>

<div id="section5" class="section"><a id="s5" name="s5" toc="s5" title="Supporting Information"></a><h3>Supporting Information</h3><div class="figshare_widget" doi="10.1371/journal.pone.0000660"></div><a name="pone.0000660.s001" id="pone.0000660.s001"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000660.s001">Figure S1. </a></strong></p><a id="article1.body1.sec5.supplementary-material1.caption1.p1" name="article1.body1.sec5.supplementary-material1.caption1.p1"></a><p class="preSiDOI">Western blot analysis for total p53, Ac-p53 (K372/383), Ac-Histone 3 (K9) in chromatin immunoprecipitated fractions of Doxorubicin treated and untreated 293 cell lysate showing the respective immunoprecipitated proteins.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000660.s001</p><a id="article1.body1.sec5.supplementary-material1.caption1.p2" name="article1.body1.sec5.supplementary-material1.caption1.p2"></a><p class="postSiDOI">(8.88 MB TIF)</p>
<a name="pone.0000660.s002" id="pone.0000660.s002"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000660.s002">Figure S2. </a></strong></p><a id="article1.body1.sec5.supplementary-material2.caption1.p1" name="article1.body1.sec5.supplementary-material2.caption1.p1"></a><p class="preSiDOI">Cell cycle analysis by FACS. 293 cells were treated with Doxorubicin with or without SMAR1 siRNA for 0–48 hrs as mentioned in the figure. Percent population in G1, S and G2 phase are represented as M1, M2 and M3 markers. The result shown is representative of five independent experiments.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000660.s002</p><a id="article1.body1.sec5.supplementary-material2.caption1.p2" name="article1.body1.sec5.supplementary-material2.caption1.p2"></a><p class="postSiDOI">(6.00 MB TIF)</p>
<a name="pone.0000660.s003" id="pone.0000660.s003"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000660.s003">Figure S3. </a></strong></p><a id="article1.body1.sec5.supplementary-material3.caption1.p1" name="article1.body1.sec5.supplementary-material3.caption1.p1"></a><p class="preSiDOI">Western blot analysis for Cyclin D3, p27, Cyclin D1, Cyclin E, Cyclin A with β-actin as loading control in synchronized 293 cells upon 0.5 µM treatment of Doxorubicin with or with out SMAR1 siRNA (100 nM) after various time points corresponding to the FACS samples(A and B).</p>
<p class="siDoi">doi:10.1371/journal.pone.0000660.s003</p><a id="article1.body1.sec5.supplementary-material3.caption1.p2" name="article1.body1.sec5.supplementary-material3.caption1.p2"></a><p class="postSiDOI">(10.44 MB TIF)</p>
<a name="pone.0000660.s004" id="pone.0000660.s004"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000660.s004">Figure S4. </a></strong></p><a id="article1.body1.sec5.supplementary-material4.caption1.p1" name="article1.body1.sec5.supplementary-material4.caption1.p1"></a><p class="preSiDOI">Immuno-fluorescence confocal analysis for phosphor-serine 15 p53 using rabbit polyclonal α-p53 ser-15 primary antibody and was detected by goat α-rabbit-Cy3 secondary antibody in Fibroadenoma (A) and Infiltrating Ductal Carcinoma grade III (B) breast cancer sample. DAPI was used to counter stain nucleus.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000660.s004</p><a id="article1.body1.sec5.supplementary-material4.caption1.p2" name="article1.body1.sec5.supplementary-material4.caption1.p2"></a><p class="postSiDOI">(7.71 MB TIF)</p>
<a name="pone.0000660.s005" id="pone.0000660.s005"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000660.s005">Figure S5. </a></strong></p><a id="article1.body1.sec5.supplementary-material5.caption1.p1" name="article1.body1.sec5.supplementary-material5.caption1.p1"></a><p class="preSiDOI">Wound healing assay in control MCF7 (A) and PC3 cells (B) or in cells transiently transfected with SMAR1. Images represent control cells and SMAR1 siRNA transfected cells at 0 hr and after 24 hr of transfection.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000660.s005</p><a id="article1.body1.sec5.supplementary-material5.caption1.p2" name="article1.body1.sec5.supplementary-material5.caption1.p2"></a><p class="postSiDOI">(7.66 MB TIF)</p>
<a name="pone.0000660.s006" id="pone.0000660.s006"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000660.s006">Table S1. </a></strong></p><a id="article1.body1.sec5.supplementary-material6.caption1.p1" name="article1.body1.sec5.supplementary-material6.caption1.p1"></a><p class="preSiDOI">Percent population shift towards G1/S and G2/M phase in Doxorubicin (0.5 µM) treated with and without siRNA (100 nM) compared to control untreated synchronized 293 cells.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000660.s006</p><a id="article1.body1.sec5.supplementary-material6.caption1.p2" name="article1.body1.sec5.supplementary-material6.caption1.p2"></a><p class="postSiDOI">(0.03 MB DOC)</p>
<a name="pone.0000660.s007" id="pone.0000660.s007"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000660.s007">Video S1. </a></strong></p><a id="article1.body1.sec5.supplementary-material7.caption1.p1" name="article1.body1.sec5.supplementary-material7.caption1.p1"></a><p class="preSiDOI">Time lapse video showing migration of control B16F1 cells.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000660.s007</p><a id="article1.body1.sec5.supplementary-material7.caption1.p2" name="article1.body1.sec5.supplementary-material7.caption1.p2"></a><p class="postSiDOI">(1.61 MB MOV)</p>
<a name="pone.0000660.s008" id="pone.0000660.s008"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000660.s008">Video S2. </a></strong></p><a id="article1.body1.sec5.supplementary-material8.caption1.p1" name="article1.body1.sec5.supplementary-material8.caption1.p1"></a><p class="preSiDOI">Time lapse video showing migration of SMAR1 stable B16F1 cells.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000660.s008</p><a id="article1.body1.sec5.supplementary-material8.caption1.p2" name="article1.body1.sec5.supplementary-material8.caption1.p2"></a><p class="postSiDOI">(1.62 MB MOV)</p>
<a name="pone.0000660.s009" id="pone.0000660.s009"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0000660.s009">Video S3. </a></strong></p><a id="article1.body1.sec5.supplementary-material9.caption1.p1" name="article1.body1.sec5.supplementary-material9.caption1.p1"></a><p class="preSiDOI">Time lapse video showing migration of SMAR1 siRNA treated B16F1 cells.</p>
<p class="siDoi">doi:10.1371/journal.pone.0000660.s009</p><a id="article1.body1.sec5.supplementary-material9.caption1.p2" name="article1.body1.sec5.supplementary-material9.caption1.p2"></a><p class="postSiDOI">(1.60 MB MOV)</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>We thank Dr. Moshe Oren for providing wild type and mutant p53 expressing plasmids. We thank Dr. G.C. Mishra, Director, National Centre for Cell Science (NCCS). We thank Dr. Avinash Pradhan, M.D., Chief Pathologist, KEM Hospital, Pune; Head of the Department and all Professors from Department of Pathology, AFMC, Pune for providing human breast cancer samples and their technical help. We also thank Dr. Anjali Shiras, Scientist D, NCCS; Dr. B. Ramanamurty, Animal Facilty Incharge, NCCS; Mr. Md. Sheikh, NCCS; Ms. Hemangini Shikhara, NCCS and Ms.Ashwini Atre, NCCS for technical assistance.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: SC KS. Performed the experiments: KS DM RO RG. Analyzed the data: SC KS RG GP RG. Contributed reagents/materials/analysis tools: SC GP. Wrote the paper: SC KS GP.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0000660-Zink1" id="pone.0000660-Zink1"></a>Zink D, Fischer AH, Nickerson JA (2004) Nuclear structure in cancer cells. Nat Rev Cancer  4: 677–687.  <ul class="find" data-citedArticleID="970488" data-doi="10.1038/nrc1430"><li><a href="http://dx.doi.org/10.1038/nrc1430" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Nuclear+structure+in+cancer+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Nuclear+structure+in+cancer+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0000660-Galande1" id="pone.0000660-Galande1"></a>Galande S (2002) Chromatin (dis)organization and cancer: BUR-binding proteins as biomarkers for cancer. Curr Cancer Drug Targets  2: 157–190.  <ul class="find" data-citedArticleID="970420" data-doi="10.2174/1568009023333917"><li><a href="http://dx.doi.org/10.2174/1568009023333917" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Chromatin+%28dis%29organization+and+cancer%3A+BUR-binding+proteins+as+biomarkers+for+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Chromatin+%28dis%29organization+and+cancer%3A+BUR-binding+proteins+as+biomarkers+for+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0000660-Hollstein1" id="pone.0000660-Hollstein1"></a>Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, et al.  (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res  22: 3551–3555.  <ul class="find" data-citedArticleID="970432" data-doi="10.1093/nar/25.1.151"><li><a href="http://dx.doi.org/10.1093/nar/25.1.151" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Database+of+p53+gene+somatic+mutations+in+human+tumors+and+cell+lines." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Database+of+p53+gene+somatic+mutations+in+human+tumors+and+cell+lines.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0000660-Gohler1" id="pone.0000660-Gohler1"></a>Gohler T, Jager S, Warnecke G, Yasuda H, Kim E, et al.  (2005) Mutant p53 proteins bind DNA in a DNA structure-selective mode. Nucleic Acids Res  33: 1087–1100.  <ul class="find" data-citedArticleID="970422" data-doi="10.1093/nar/gki252"><li><a href="http://dx.doi.org/10.1093/nar/gki252" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mutant+p53+proteins+bind+DNA+in+a+DNA+structure-selective+mode." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mutant+p53+proteins+bind+DNA+in+a+DNA+structure-selective+mode.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0000660-Vogelstein1" id="pone.0000660-Vogelstein1"></a>Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature  408: 307–310.  <ul class="find" data-citedArticleID="970480" data-doi="10.1038/35042675"><li><a href="http://dx.doi.org/10.1038/35042675" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Surfing+the+p53+network." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Surfing+the+p53+network.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0000660-Appella1" id="pone.0000660-Appella1"></a>Appella E, Anderson CW (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem  268: 2764–2772.  <ul class="find" data-citedArticleID="970394" data-doi="10.1046/j.1432-1327.2001.02225.x"><li><a href="http://dx.doi.org/10.1046/j.1432-1327.2001.02225.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Post-translational+modifications+and+activation+of+p53+by+genotoxic+stresses." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Post-translational+modifications+and+activation+of+p53+by+genotoxic+stresses.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0000660-Prives1" id="pone.0000660-Prives1"></a>Prives C, Manley JL (2001) Why is p53 acetylated? Cell  107: 815–818.  <ul class="find" data-citedArticleID="970466" data-doi="10.1016/s0092-8674(01)00619-5"><li><a href="http://dx.doi.org/10.1016/s0092-8674(01)00619-5" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Why+is+p53+acetylated%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Why+is+p53+acetylated%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0000660-Feng1" id="pone.0000660-Feng1"></a>Feng L, Lin T, Uranishi H, Gu W, Xu Y (2005) Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol  25: 5389–5395.  <ul class="find" data-citedArticleID="970418" data-doi="10.1128/mcb.25.13.5389-5395.2005"><li><a href="http://dx.doi.org/10.1128/mcb.25.13.5389-5395.2005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Functional+analysis+of+the+roles+of+posttranslational+modifications+at+the+p53+C+terminus+in+regulating+p53+stability+and+activity." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Functional+analysis+of+the+roles+of+posttranslational+modifications+at+the+p53+C+terminus+in+regulating+p53+stability+and+activity.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0000660-Vaghefi1" id="pone.0000660-Vaghefi1"></a>Vaghefi H, Neet KE (2004) Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation. Oncogene  23: 8078–8087.  <ul class="find" data-citedArticleID="970478" data-doi="10.1038/sj.onc.1207953"><li><a href="http://dx.doi.org/10.1038/sj.onc.1207953" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Deacetylation+of+p53+after+nerve+growth+factor+treatment+in+PC12+cells+as+a+post-translational+modification+mechanism+of+neurotrophin-induced+tumor+suppressor+activation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Deacetylation+of+p53+after+nerve+growth+factor+treatment+in+PC12+cells+as+a+post-translational+modification+mechanism+of+neurotrophin-induced+tumor+suppressor+activation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0000660-Roy1" id="pone.0000660-Roy1"></a>Roy S, Packman K, Jeffrey R, Tenniswood M (2005) Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells. Cell Death Differ  12: 482–491.  <ul class="find" data-citedArticleID="970470" data-doi="10.1038/sj.cdd.4401581"><li><a href="http://dx.doi.org/10.1038/sj.cdd.4401581" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Histone+deacetylase+inhibitors+differentially+stabilize+acetylated+p53+and+induce+cell+cycle+arrest+or+apoptosis+in+prostate+cancer+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Histone+deacetylase+inhibitors+differentially+stabilize+acetylated+p53+and+induce+cell+cycle+arrest+or+apoptosis+in+prostate+cancer+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0000660-Yu1" id="pone.0000660-Yu1"></a>Yu Q, Geng Y, Sicinski P (2001) Specific protection against breast cancers by Cyclin D1 ablation. Nature  411: 1017–1021.  <ul class="find" data-citedArticleID="970484" data-doi="10.1038/35082500"><li><a href="http://dx.doi.org/10.1038/35082500" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Specific+protection+against+breast+cancers+by+Cyclin+D1+ablation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Specific+protection+against+breast+cancers+by+Cyclin+D1+ablation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0000660-Buckley1" id="pone.0000660-Buckley1"></a>Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, et al.  (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene  8: 2127–2133.  <ul class="find" data-citedArticleID="970406"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Expression+and+amplification+of+cyclin+genes+in+human+breast+cancer.&amp;auth=&amp;atitle=Expression+and+amplification+of+cyclin+genes+in+human+breast+cancer." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Expression+and+amplification+of+cyclin+genes+in+human+breast+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Expression+and+amplification+of+cyclin+genes+in+human+breast+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0000660-Lee1" id="pone.0000660-Lee1"></a>Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, et al.  (1999) pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. J Biol Chem  274: 7341–7350.  <ul class="find" data-citedArticleID="970452" data-doi="10.1074/jbc.274.11.7341"><li><a href="http://dx.doi.org/10.1074/jbc.274.11.7341" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=pp60%28v-src%29+induction+of+cyclin+D1+requires+collaborative+interactions+between+the+extracellular+signal-regulated+kinase%2C+p38%2C+and+Jun+kinase+pathways.+A+role+for+cAMP+response+element-binding+protein+and+activating+transcription+factor-2+in+pp60%28v-src%29+signaling+in+breast+cancer+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22pp60%28v-src%29+induction+of+cyclin+D1+requires+collaborative+interactions+between+the+extracellular+signal-regulated+kinase%2C+p38%2C+and+Jun+kinase+pathways.+A+role+for+cAMP+response+element-binding+protein+and+activating+transcription+factor-2+in+pp60%28v-src%29+signaling+in+breast+cancer+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0000660-Holnthoner1" id="pone.0000660-Holnthoner1"></a>Holnthoner W, Pillinger M, Groger M, Wolff K, Ashton AW, et al.  (2002) Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells. J Biol Chem  277: 45847–45853.  <ul class="find" data-citedArticleID="970434" data-doi="10.1074/jbc.m209354200"><li><a href="http://dx.doi.org/10.1074/jbc.m209354200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Fibroblast+growth+factor-2+induces+Lef%2FTcf-dependent+transcription+in+human+endothelial+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Fibroblast+growth+factor-2+induces+Lef%2FTcf-dependent+transcription+in+human+endothelial+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0000660-Beier1" id="pone.0000660-Beier1"></a>Beier F, Ali Z, Mok D, Taylor AC, Leask T, et al.  (2001) TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. Mol Biol Cell  12: 3852–3863.  <ul class="find" data-citedArticleID="970400" data-doi="10.1091/mbc.12.12.3852"><li><a href="http://dx.doi.org/10.1091/mbc.12.12.3852" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=TGFbeta+and+PTHrP+control+chondrocyte+proliferation+by+activating+cyclin+D1+expression." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22TGFbeta+and+PTHrP+control+chondrocyte+proliferation+by+activating+cyclin+D1+expression.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0000660-Suzui1" id="pone.0000660-Suzui1"></a>Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, et al.  (2002) Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21 (CIP1) and inhibition of expression of cyclin D1. Cancer Res  62: 3997–4006.  <ul class="find" data-citedArticleID="970476"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Growth+inhibition+of+human+hepatoma+cells+by+acyclic+retinoid+is+associated+with+induction+of+p21+%28CIP1%29+and+inhibition+of+expression+of+cyclin+D1.&amp;auth=&amp;atitle=Growth+inhibition+of+human+hepatoma+cells+by+acyclic+retinoid+is+associated+with+induction+of+p21+%28CIP1%29+and+inhibition+of+expression+of+cyclin+D1." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Growth+inhibition+of+human+hepatoma+cells+by+acyclic+retinoid+is+associated+with+induction+of+p21+%28CIP1%29+and+inhibition+of+expression+of+cyclin+D1." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Growth+inhibition+of+human+hepatoma+cells+by+acyclic+retinoid+is+associated+with+induction+of+p21+%28CIP1%29+and+inhibition+of+expression+of+cyclin+D1.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0000660-Albanese1" id="pone.0000660-Albanese1"></a>Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, et al.  (1995) Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem  270: 23589–23597.  <ul class="find" data-citedArticleID="970392" data-doi="10.1074/jbc.270.40.23589"><li><a href="http://dx.doi.org/10.1074/jbc.270.40.23589" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Transforming+p21ras+mutants+and+c-Ets-2+activate+the+cyclin+D1+promoter+through+distinguishable+regions." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Transforming+p21ras+mutants+and+c-Ets-2+activate+the+cyclin+D1+promoter+through+distinguishable+regions.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0000660-Matsumura1" id="pone.0000660-Matsumura1"></a>Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, et al.  (1999) Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J  18: 1367–1377.  <ul class="find" data-citedArticleID="970456" data-doi="10.1093/emboj/18.5.1367"><li><a href="http://dx.doi.org/10.1093/emboj/18.5.1367" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Transcriptional+regulation+of+the+cyclin+D1+promoter+by+STAT5%3A+its+involvement+in+cytokine-dependent+growth+of+hematopoietic+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Transcriptional+regulation+of+the+cyclin+D1+promoter+by+STAT5%3A+its+involvement+in+cytokine-dependent+growth+of+hematopoietic+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0000660-Lee2" id="pone.0000660-Lee2"></a>Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, et al.  (2000) Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol Cell Biol  20: 672–683.  <ul class="find" data-citedArticleID="970454" data-doi="10.1128/mcb.20.2.672-683.2000"><li><a href="http://dx.doi.org/10.1128/mcb.20.2.672-683.2000" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cyclin+D1+is+required+for+transformation+by+activated+Neu+and+is+induced+through+an+E2F-dependent+signaling+pathway." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cyclin+D1+is+required+for+transformation+by+activated+Neu+and+is+induced+through+an+E2F-dependent+signaling+pathway.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0000660-MuraokaCook1" id="pone.0000660-MuraokaCook1"></a>Muraoka-Cook RS, Dumont N, Arteaga CL (2005) Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression. Clin. Cancer Res  11: 937–943.  <ul class="find" data-citedArticleID="970462"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Dual+role+of+transforming+growth+factor+beta+in+mammary+tumorigenesis+and+metastatic+progression.+Clin.&amp;auth=&amp;atitle=Dual+role+of+transforming+growth+factor+beta+in+mammary+tumorigenesis+and+metastatic+progression.+Clin." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Dual+role+of+transforming+growth+factor+beta+in+mammary+tumorigenesis+and+metastatic+progression.+Clin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Dual+role+of+transforming+growth+factor+beta+in+mammary+tumorigenesis+and+metastatic+progression.+Clin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0000660-Kang1" id="pone.0000660-Kang1"></a>Kang Y, He W, Tulley S, Gupta GP, Serganova I, et al.  (2005) Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci USA  102: 13909–13914.  <ul class="find" data-citedArticleID="970440" data-doi="10.1073/pnas.0506517102"><li><a href="http://dx.doi.org/10.1073/pnas.0506517102" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Breast+cancer+bone+metastasis+mediated+by+the+Smad+tumor+suppressor+pathway." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Breast+cancer+bone+metastasis+mediated+by+the+Smad+tumor+suppressor+pathway.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0000660-Yakymovych1" id="pone.0000660-Yakymovych1"></a>Yakymovych I, Ten Dijke P, Heldin CH, Souchelnytskyi S (2001) Regulation of Smad signaling by protein kinase C. FASEB J 15: 553–555.  <ul class="find" data-citedArticleID="970482" data-doi="10.1096/fj.00-0474fje"><li><a href="http://dx.doi.org/10.1096/fj.00-0474fje" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Regulation+of+Smad+signaling+by+protein+kinase+C.+FASEB+J" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Regulation+of+Smad+signaling+by+protein+kinase+C.+FASEB+J%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0000660-deCaestecker1" id="pone.0000660-deCaestecker1"></a>de Caestecker MP, Parks WT, Frank CJ, Castagnino P, Bottaro DP, et al.  (1998) Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev  12: 1587–1592.  <ul class="find" data-citedArticleID="970490" data-doi="10.1101/gad.12.11.1587"><li><a href="http://dx.doi.org/10.1101/gad.12.11.1587" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Smad2+transduces+common+signals+from+receptor+serine-threonine+and+tyrosine+kinases." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Smad2+transduces+common+signals+from+receptor+serine-threonine+and+tyrosine+kinases.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0000660-Chacko1" id="pone.0000660-Chacko1"></a>Chacko BM, Qin B, Correia JJ, Lam SS, de Caestecker MP, et al.  (2001) The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization. Nat Struct Biol  8: 248–253.  <ul class="find" data-citedArticleID="970408"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=The+L3+loop+and+C-terminal+phosphorylation+jointly+define+Smad+protein+trimerization.&amp;auth=&amp;atitle=The+L3+loop+and+C-terminal+phosphorylation+jointly+define+Smad+protein+trimerization." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+L3+loop+and+C-terminal+phosphorylation+jointly+define+Smad+protein+trimerization." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+L3+loop+and+C-terminal+phosphorylation+jointly+define+Smad+protein+trimerization.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0000660-Chen1" id="pone.0000660-Chen1"></a>Chen HB, Rud JG, Lin K, Xu L (2005) Nuclear targeting of transforming growth factor-beta-activated Smad complexes. J Biol Chem  280: 21329–21336.  <ul class="find" data-citedArticleID="970412" data-doi="10.1074/jbc.m500362200"><li><a href="http://dx.doi.org/10.1074/jbc.m500362200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Nuclear+targeting+of+transforming+growth+factor-beta-activated+Smad+complexes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Nuclear+targeting+of+transforming+growth+factor-beta-activated+Smad+complexes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0000660-Michl1" id="pone.0000660-Michl1"></a>Michl P, Ramjaun AR, Pardo OE, Warne PH, Wagner M, et al.  (2005) CUTL1 is a target of TGF (beta) signaling that enhances cancer cell motility and invasiveness. Cancer Cell  7: 521–532.  <ul class="find" data-citedArticleID="970460" data-doi="10.1016/j.ccr.2005.05.018"><li><a href="http://dx.doi.org/10.1016/j.ccr.2005.05.018" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CUTL1+is+a+target+of+TGF+%28beta%29+signaling+that+enhances+cancer+cell+motility+and+invasiveness." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CUTL1+is+a+target+of+TGF+%28beta%29+signaling+that+enhances+cancer+cell+motility+and+invasiveness.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0000660-Zhu1" id="pone.0000660-Zhu1"></a>Zhu Q, Maitra U, Johnston D, Lozano M, Dudley JP (2004) The homeodomain protein CDP regulates mammary-specific gene transcription and tumorigenesis. Mol Cell Biol  24: 4810–4823.  <ul class="find" data-citedArticleID="970486" data-doi="10.1128/mcb.24.11.4810-4823.2004"><li><a href="http://dx.doi.org/10.1128/mcb.24.11.4810-4823.2004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+homeodomain+protein+CDP+regulates+mammary-specific+gene+transcription+and+tumorigenesis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+homeodomain+protein+CDP+regulates+mammary-specific+gene+transcription+and+tumorigenesis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0000660-Nepveu1" id="pone.0000660-Nepveu1"></a>Nepveu A (2001) Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene  270: 1–15.  <ul class="find" data-citedArticleID="970464" data-doi="10.1016/s0378-1119(01)00485-1"><li><a href="http://dx.doi.org/10.1016/s0378-1119(01)00485-1" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Role+of+the+multifunctional+CDP%2FCut%2FCux+homeodomain+transcription+factor+in+regulating+differentiation%2C+cell+growth+and+development." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Role+of+the+multifunctional+CDP%2FCut%2FCux+homeodomain+transcription+factor+in+regulating+differentiation%2C+cell+growth+and+development.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0000660-Chattopadhyay1" id="pone.0000660-Chattopadhyay1"></a>Chattopadhyay S, Kaul R, Charest A, Housman D, Chen J (2000) SMAR1, a novel, alternatively spliced gene product, binds the Scaffold/Matrix-associated region at the T cell receptor beta locus. Genomics  68: 93–96.  <ul class="find" data-citedArticleID="970410" data-doi="10.1006/geno.2000.6279"><li><a href="http://dx.doi.org/10.1006/geno.2000.6279" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=SMAR1%2C+a+novel%2C+alternatively+spliced+gene+product%2C+binds+the+Scaffold%2FMatrix-associated+region+at+the+T+cell+receptor+beta+locus." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22SMAR1%2C+a+novel%2C+alternatively+spliced+gene+product%2C+binds+the+Scaffold%2FMatrix-associated+region+at+the+T+cell+receptor+beta+locus.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0000660-KaulGhanekar1" id="pone.0000660-KaulGhanekar1"></a>Kaul-Ghanekar R, Majumdar S, Jalota A, Gulati N, Dubey N, et al.  (2005) Abnormal V(D)J recombination of T cell receptor beta locus in SMAR1 transgenic mice. J Biol Chem  280: 9450–9459.  <ul class="find" data-citedArticleID="970444" data-doi="10.1074/jbc.m412206200"><li><a href="http://dx.doi.org/10.1074/jbc.m412206200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Abnormal+V%28D%29J+recombination+of+T+cell+receptor+beta+locus+in+SMAR1+transgenic+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Abnormal+V%28D%29J+recombination+of+T+cell+receptor+beta+locus+in+SMAR1+transgenic+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0000660-KaulGhanekar2" id="pone.0000660-KaulGhanekar2"></a>Kaul-Ghanekar R, Jalota A, Pavithra L, Tucker P, Chattopadhyay S (2004) SMAR1 and Cux/CDP modulate chromatin and act as negative regulators of the TCRbeta enhancer (Ebeta). Nucleic Acids Res  32: 4862–4875.  <ul class="find" data-citedArticleID="970446" data-doi="10.1093/nar/gkh807"><li><a href="http://dx.doi.org/10.1093/nar/gkh807" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=SMAR1+and+Cux%2FCDP+modulate+chromatin+and+act+as+negative+regulators+of+the+TCRbeta+enhancer+%28Ebeta%29." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22SMAR1+and+Cux%2FCDP+modulate+chromatin+and+act+as+negative+regulators+of+the+TCRbeta+enhancer+%28Ebeta%29.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0000660-Birot1" id="pone.0000660-Birot1"></a>Birot A, Duret L, Bartholin L, Santalucia B, Tigaud I, et al.  (2000) Identification and molecular analysis of BANP. Gene  253: 189–196.  <ul class="find" data-citedArticleID="970402" data-doi="10.1016/s0378-1119(00)00244-4"><li><a href="http://dx.doi.org/10.1016/s0378-1119(00)00244-4" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Identification+and+molecular+analysis+of+BANP." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Identification+and+molecular+analysis+of+BANP.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0000660-Kochetkova1" id="pone.0000660-Kochetkova1"></a>Kochetkova M, McKenzie OL, Bais AJ, Martin JM, Secker GA, et al.  (2002) CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3. Cancer Res  62: 4599–4604.  <ul class="find" data-citedArticleID="970448"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=CBFA2T3+%28MTG16%29+is+a+putative+breast+tumor+suppressor+gene+from+the+breast+cancer+loss+of+heterozygosity+region+at+16q24.3.&amp;auth=&amp;atitle=CBFA2T3+%28MTG16%29+is+a+putative+breast+tumor+suppressor+gene+from+the+breast+cancer+loss+of+heterozygosity+region+at+16q24.3." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CBFA2T3+%28MTG16%29+is+a+putative+breast+tumor+suppressor+gene+from+the+breast+cancer+loss+of+heterozygosity+region+at+16q24.3." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CBFA2T3+%28MTG16%29+is+a+putative+breast+tumor+suppressor+gene+from+the+breast+cancer+loss+of+heterozygosity+region+at+16q24.3.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0000660-Harkonen1" id="pone.0000660-Harkonen1"></a>Harkonen P, Kyllonen AP, Nordling S, Vihko P (2005) Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer. Prostate  62: 267–274.  <ul class="find" data-citedArticleID="970426" data-doi="10.1002/pros.20147"><li><a href="http://dx.doi.org/10.1002/pros.20147" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Loss+of+heterozygosity+in+chromosomal+region+16q24.3+associated+with+progression+of+prostate+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Loss+of+heterozygosity+in+chromosomal+region+16q24.3+associated+with+progression+of+prostate+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0000660-CletonJansen1" id="pone.0000660-CletonJansen1"></a>Cleton-Jansen AM, Callen DF, Seshadri R, Goldup S, Mccallum B, et al.  (2001) Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Res  61: 1171–1177.  <ul class="find" data-citedArticleID="970414"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Loss+of+heterozygosity+mapping+at+chromosome+arm+16q+in+712+breast+tumors+reveals+factors+that+influence+delineation+of+candidate+regions.&amp;auth=&amp;atitle=Loss+of+heterozygosity+mapping+at+chromosome+arm+16q+in+712+breast+tumors+reveals+factors+that+influence+delineation+of+candidate+regions." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Loss+of+heterozygosity+mapping+at+chromosome+arm+16q+in+712+breast+tumors+reveals+factors+that+influence+delineation+of+candidate+regions." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Loss+of+heterozygosity+mapping+at+chromosome+arm+16q+in+712+breast+tumors+reveals+factors+that+influence+delineation+of+candidate+regions.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0000660-Rampalli1" id="pone.0000660-Rampalli1"></a>Rampalli S, Pavithra L, Bhatt A, Kundu TK, Chattopadhyay S (2005) Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. Mol Cell Biol  25: 8415–8429.  <ul class="find" data-citedArticleID="970468" data-doi="10.1128/mcb.25.19.8415-8429.2005"><li><a href="http://dx.doi.org/10.1128/mcb.25.19.8415-8429.2005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tumor+suppressor+SMAR1+mediates+cyclin+D1+repression+by+recruitment+of+the+SIN3%2Fhistone+deacetylase+1+complex." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tumor+suppressor+SMAR1+mediates+cyclin+D1+repression+by+recruitment+of+the+SIN3%2Fhistone+deacetylase+1+complex.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0000660-Jalota1" id="pone.0000660-Jalota1"></a>Jalota A, Singh K, Pavithra L, Kaul-Ghanekar R, Jameel S, et al.  (2005) Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif. J Biol Chem  280: 16019–16029.  <ul class="find" data-citedArticleID="970436" data-doi="10.1074/jbc.m413200200"><li><a href="http://dx.doi.org/10.1074/jbc.m413200200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tumor+suppressor+SMAR1+activates+and+stabilizes+p53+through+its+arginine-serine-rich+motif." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tumor+suppressor+SMAR1+activates+and+stabilizes+p53+through+its+arginine-serine-rich+motif.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0000660-Kaul1" id="pone.0000660-Kaul1"></a>Kaul R, Mukherjee S, Ahmed F, Bhat MK, Chhipa R, et al.  (2003) Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice. Int J Cancer  103: 606–615.  <ul class="find" data-citedArticleID="970442" data-doi="10.1002/ijc.10881"><li><a href="http://dx.doi.org/10.1002/ijc.10881" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Direct+interaction+with+and+activation+of+p53+by+SMAR1+retards+cell-cycle+progression+at+G2%2FM+phase+and+delays+tumor+growth+in+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Direct+interaction+with+and+activation+of+p53+by+SMAR1+retards+cell-cycle+progression+at+G2%2FM+phase+and+delays+tumor+growth+in+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0000660-Meek1" id="pone.0000660-Meek1"></a>Meek DW (2004) The p53 response to DNA damage. DNA Repair (Amst)  3: 1049–1056.  <ul class="find" data-citedArticleID="970458" data-doi="10.1016/j.dnarep.2004.03.027"><li><a href="http://dx.doi.org/10.1016/j.dnarep.2004.03.027" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+p53+response+to+DNA+damage." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+p53+response+to+DNA+damage.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0000660-Bode1" id="pone.0000660-Bode1"></a>Bode AM, Dong Z (2004) Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer  4: 793–805.  <ul class="find" data-citedArticleID="970404" data-doi="10.1038/nrc1455"><li><a href="http://dx.doi.org/10.1038/nrc1455" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Post-translational+modification+of+p53+in+tumorigenesis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Post-translational+modification+of+p53+in+tumorigenesis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">41.
              </span><a name="pone.0000660-Azuma1" id="pone.0000660-Azuma1"></a>Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, et al.  (2005) Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst  97: 1734–1746.  <ul class="find" data-citedArticleID="970396" data-doi="10.1093/jnci/dji399"><li><a href="http://dx.doi.org/10.1093/jnci/dji399" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Effect+of+Smad7+expression+on+metastasis+of+mouse+mammary+carcinoma+JygMC%28A%29+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Effect+of+Smad7+expression+on+metastasis+of+mouse+mammary+carcinoma+JygMC%28A%29+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">42.
              </span><a name="pone.0000660-Ezzell1" id="pone.0000660-Ezzell1"></a>Ezzell RM, Goldmann WH, Wang N, Parasharama N, Ingber DE (1997) Vinculin promotes cell spreading by mechanically coupling integrins to the cytoskeleton. Exp Cell Res  231: 14–26.  <ul class="find" data-citedArticleID="970416" data-doi="10.1016/j.yexcr.2008.02.017"><li><a href="http://dx.doi.org/10.1016/j.yexcr.2008.02.017" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Vinculin+promotes+cell+spreading+by+mechanically+coupling+integrins+to+the+cytoskeleton." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Vinculin+promotes+cell+spreading+by+mechanically+coupling+integrins+to+the+cytoskeleton.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">43.
              </span><a name="pone.0000660-Goldmann1" id="pone.0000660-Goldmann1"></a>Goldmann WH, Ingber DE (2002) Intact vinculin protein is required for control of cell shape, cell mechanics, and rac-dependent lamellipodia formation. Biochem Biophys Res Commun  290: 749–755.  <ul class="find" data-citedArticleID="970424" data-doi="10.1006/bbrc.2001.6243"><li><a href="http://dx.doi.org/10.1006/bbrc.2001.6243" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Intact+vinculin+protein+is+required+for+control+of+cell+shape%2C+cell+mechanics%2C+and+rac-dependent+lamellipodia+formation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Intact+vinculin+protein+is+required+for+control+of+cell+shape%2C+cell+mechanics%2C+and+rac-dependent+lamellipodia+formation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">44.
              </span><a name="pone.0000660-Sottile1" id="pone.0000660-Sottile1"></a>Sottile J, Hocking DC, Swiatek PJ (1998) Fibronectin matrix assembly enhances adhesion-dependent cell growth. J Cell Sci  111: 2933–2943.  <ul class="find" data-citedArticleID="970472"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Fibronectin+matrix+assembly+enhances+adhesion-dependent+cell+growth.&amp;auth=&amp;atitle=Fibronectin+matrix+assembly+enhances+adhesion-dependent+cell+growth." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Fibronectin+matrix+assembly+enhances+adhesion-dependent+cell+growth." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Fibronectin+matrix+assembly+enhances+adhesion-dependent+cell+growth.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">45.
              </span><a name="pone.0000660-Sottile2" id="pone.0000660-Sottile2"></a>Sottile J, Hocking DC (2002) Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell  13: 3546–3559.  <ul class="find" data-citedArticleID="970474" data-doi="10.1091/mbc.e02-01-0048"><li><a href="http://dx.doi.org/10.1091/mbc.e02-01-0048" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Fibronectin+polymerization+regulates+the+composition+and+stability+of+extracellular+matrix+fibrils+and+cell-matrix+adhesions." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Fibronectin+polymerization+regulates+the+composition+and+stability+of+extracellular+matrix+fibrils+and+cell-matrix+adhesions.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">46.
              </span><a name="pone.0000660-LabatRobert1" id="pone.0000660-LabatRobert1"></a>Labat-Robert J (2002) Fibronectin in malignancy. Semin Cancer Biol  12: 187–195.  <ul class="find" data-citedArticleID="970450" data-doi="10.1016/s1044-579x(02)00022-6"><li><a href="http://dx.doi.org/10.1016/s1044-579x(02)00022-6" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Fibronectin+in+malignancy." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Fibronectin+in+malignancy.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">47.
              </span><a name="pone.0000660-Bazzoni1" id="pone.0000660-Bazzoni1"></a>Bazzoni G (2003) The JAM family of junctional adhesion molecules. Curr Opin Cell Biol  15: 525–530.  <ul class="find" data-citedArticleID="970398" data-doi="10.1016/s0955-0674(03)00104-2"><li><a href="http://dx.doi.org/10.1016/s0955-0674(03)00104-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+JAM+family+of+junctional+adhesion+molecules." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+JAM+family+of+junctional+adhesion+molecules.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">48.
              </span><a name="pone.0000660-JohnsonLeger1" id="pone.0000660-JohnsonLeger1"></a>Johnson-Leger CA, Aurrand-Lions M, Beltraminelli N, Fasel N, Imhof BA (2002) Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. Blood  100: 2479–2486.  <ul class="find" data-citedArticleID="970438" data-doi="10.1182/blood-2001-11-0098"><li><a href="http://dx.doi.org/10.1182/blood-2001-11-0098" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Junctional+adhesion+molecule-2+%28JAM-2%29+promotes+lymphocyte+transendothelial+migration." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Junctional+adhesion+molecule-2+%28JAM-2%29+promotes+lymphocyte+transendothelial+migration.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">49.
              </span><a name="pone.0000660-Harris1" id="pone.0000660-Harris1"></a>Harris SL, Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene  24: 2899–2908.  <ul class="find" data-citedArticleID="970428" data-doi="10.1038/sj.onc.1208615"><li><a href="http://dx.doi.org/10.1038/sj.onc.1208615" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+p53+pathway%3A+positive+and+negative+feedback+loops." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+p53+pathway%3A+positive+and+negative+feedback+loops.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">50.
              </span><a name="pone.0000660-Henderson1" id="pone.0000660-Henderson1"></a>Henderson IC (1991) Chemotherapy for metastatic disease. Breast Disease, 2<sup>nd</sup> ed. pp. 504–625.  <ul class="find-nolinks"></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.XML" value="135505"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.PDF" value="3856549"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g001.PNG_L" value="2933788"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g001.PNG_M" value="508118"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g001.PNG_S" value="21316"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g001.TIF" value="3980872"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g001.PNG_I" value="219840"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g002.PNG_L" value="463726"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g002.PNG_M" value="99624"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g002.PNG_S" value="9245"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g002.TIF" value="786842"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g002.PNG_I" value="35033"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g003.PNG_L" value="650212"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g003.PNG_M" value="150096"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g003.PNG_S" value="14084"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g003.TIF" value="1160500"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g003.PNG_I" value="58930"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g004.PNG_L" value="715810"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g004.PNG_M" value="199143"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g004.PNG_S" value="16623"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g004.TIF" value="970082"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g004.PNG_I" value="92050"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g005.PNG_L" value="1704884"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g005.PNG_M" value="348673"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g005.PNG_S" value="18330"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g005.TIF" value="2493440"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g005.PNG_I" value="120629"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g006.PNG_L" value="1536281"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g006.PNG_M" value="356447"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g006.PNG_S" value="16576"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g006.TIF" value="1862882"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g006.PNG_I" value="127512"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g007.PNG_L" value="1590047"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g007.PNG_M" value="212699"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g007.PNG_S" value="8967"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g007.TIF" value="2453978"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g007.PNG_I" value="66828"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.t001.PNG_L" value="306388"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.t001.PNG_M" value="158183"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.t001.PNG_S" value="16535"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.t001.TIF" value="1496734"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.t001.PNG_I" value="50148"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.t002.PNG_L" value="185893"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.t002.PNG_M" value="100413"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.t002.PNG_S" value="12180"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.t002.TIF" value="900362"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.t002.PNG_I" value="29929"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g008.PNG_L" value="1288286"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g008.PNG_M" value="351725"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g008.PNG_S" value="18265"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g008.TIF" value="1793074"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g008.PNG_I" value="123637"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g009.PNG_L" value="1016635"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g009.PNG_M" value="258244"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g009.PNG_S" value="13337"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g009.TIF" value="1373396"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.g009.PNG_I" value="84350"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.s001.TIF" value="8887670"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.s002.TIF" value="6008500"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.s003.TIF" value="10449932"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.s004.TIF" value="7728852"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.s005.TIF" value="7666494"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.s006.DOC" value="26112"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.s007.MOV" value="1613600"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.s008.MOV" value="1619036"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000660.s009.MOV" value="1601460"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000660&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000660" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000660&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0000660&volume=&issue=&title=p53 Target Gene SMAR1 Is Dysregulated in Breast Cancer: Its Role in Cancer Cell Migration and Invasion&author_name=Kamini%20Singh%2C%20Devraj%20Mogare%2C%20Ramprasad%20Obula%20Giridharagopalan%2C%20Rajinikanth%20Gogiraju%2C%20Gopal%20Pande%2C%20Samit%20Chattopadhyay&start_page=1&end_page=16" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000660" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000660" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0000660" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000660&amp;t=p53%20Target%20Gene%20SMAR1%20Is%20Dysregulated%20in%20Breast%20Cancer%3A%20Its%20Role%20in%20Cancer%20Cell%20Migration%20and%20Invasion" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000660&title=p53%20Target%20Gene%20SMAR1%20Is%20Dysregulated%20in%20Breast%20Cancer%3A%20Its%20Role%20in%20Cancer%20Cell%20Migration%20and%20Invasion&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000660&amp;title=p53%20Target%20Gene%20SMAR1%20Is%20Dysregulated%20in%20Breast%20Cancer%3A%20Its%20Role%20in%20Cancer%20Cell%20Migration%20and%20Invasion" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000660" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0000660&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'p53 Target Gene SMAR1 Is Dysregulated in Breast Cancer: Its Role in Cancer Cell Migration and Invasion';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0000660';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20p53%20Target%20Gene%20SMAR1%20Is%20Dysregulated%20in%20Breast%20Cancer%3A%20Its%20Role%20in%20Cancer%20Cell%20Migration%20and%20Invasion http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000660" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0000660" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">











          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Acetylation%22" title="Search for articles in the subject area:'Acetylation'"><div class="flagText">Acetylation</div></a>
              <div data-categoryid="21455" data-articleid="24158"
                   data-categoryname="Acetylation"
                   class="flagImage" title="Flag 'Acetylation' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Breast+cancer%22" title="Search for articles in the subject area:'Breast cancer'"><div class="flagText">Breast cancer</div></a>
              <div data-categoryid="18763" data-articleid="24158"
                   data-categoryname="Breast cancer"
                   class="flagImage" title="Flag 'Breast cancer' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cancer+cell+migration%22" title="Search for articles in the subject area:'Cancer cell migration'"><div class="flagText">Cancer cell migration</div></a>
              <div data-categoryid="33965" data-articleid="24158"
                   data-categoryname="Cancer cell migration"
                   class="flagImage" title="Flag 'Cancer cell migration' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cell+cycle+and+cell+division%22" title="Search for articles in the subject area:'Cell cycle and cell division'"><div class="flagText">Cell cycle and cell division</div></a>
              <div data-categoryid="17353" data-articleid="24158"
                   data-categoryname="Cell cycle and cell division"
                   class="flagImage" title="Flag 'Cell cycle and cell division' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cell+migration%22" title="Search for articles in the subject area:'Cell migration'"><div class="flagText">Cell migration</div></a>
              <div data-categoryid="17279" data-articleid="24158"
                   data-categoryname="Cell migration"
                   class="flagImage" title="Flag 'Cell migration' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cyclins%22" title="Search for articles in the subject area:'Cyclins'"><div class="flagText">Cyclins</div></a>
              <div data-categoryid="22357" data-articleid="24158"
                   data-categoryname="Cyclins"
                   class="flagImage" title="Flag 'Cyclins' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22HEK+293+cells%22" title="Search for articles in the subject area:'HEK 293 cells'"><div class="flagText">HEK 293 cells</div></a>
              <div data-categoryid="19937" data-articleid="24158"
                   data-categoryname="HEK 293 cells"
                   class="flagImage" title="Flag 'HEK 293 cells' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Small+interfering+RNA%22" title="Search for articles in the subject area:'Small interfering RNA'"><div class="flagText">Small interfering RNA</div></a>
              <div data-categoryid="19855" data-articleid="24158"
                   data-categoryname="Small interfering RNA"
                   class="flagImage" title="Flag 'Small interfering RNA' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=4017'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=6634'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=4030&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>

<div class="block sidebar-comments">
    <div class="header">
        <h3>Comments</h3>
    </div>
      <p><a href="/annotation/listThread.action?root=42405"></a><br>Posted by Ramprasad</p>
      <p><a href="/annotation/listThread.action?root=8951">Referee Comments: Referee 1</a><br>Posted by PLoS_ONE_Group</p>
</div>

</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
